Magnetically-targeted, technetium 99m-labeled nanoparticles to the inner ear

Journal of Biomedical Nanotechnology

Volumn 4, Issue 2, 2008, Pages 174-184

  Dormer, K J ^a   Awasthi, V ^c   Galbraith, W ^c   Kopke, R D ^b   Chen, K ^b   Wassel, R ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b HOUGH EAR INSTITUTE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Cochlea; Magnetic; Nanoparticle; PLGA; Radionuclide; Technetium

Indexed keywords

MAGNETITE; NANOCOMPOSITE; NANOPARTICLE; POLYGLACTIN; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COCHLEA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EARDRUM; GAMMA SCINTIGRAPHY; GUINEA PIG; INNER EAR; ISOTOPE LABELING; MAGNET; MAGNETISM; NANOENCAPSULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PERILYMPH;

EID: 58149100453     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. D. J. Lee, O. Gomez-Martin, B. L. Lam, and D. D. Zheng, Trends in hearing impairment in United States adults: The national health interview survey, 1986-1995. J. Gerontol.: Med. Sci. 59A, 1186 ( 2006).
2. T. Endo, T. Nakagawa, T. Kita, F. Iguchi, T. S. Kim, T. Tamura, K. Iwai, Y. Tabata, and J. Ito, Novel strategy for treatment of inner ears using a biodegradable gel. Laryngoscope 115, 2016 (2005).
3. J. Dobson, Magnetic micro-and nano-particle based targeting for drug and gene delivery. Nanomedicine 1, 31 (2006).
4. D. Leslie-Pelecky, V. Labhasetwar, and R. H. Kraus, Advanced Magnetic Nanostructures, edited by D. J. Sellmyer and R. Skomski, Springer Publishing, New York (2006), pp. 461-490.
5. A. S. Lubbe, C. Bergeman, F. Schriever, P. Reichardt, K. Possinger, M. Matthias, B. Dorken, F. Herrmann, R. Gurtler, P. Hohenberger, N. Hass, R. Sohr, B. Sander, A. J. Lemke, D. Oblendorf, W. Huhnt, and D. Huhn, Preclinical experiences with magnetic drug targeting: Tolerance and efficiency. Cancer Res. 56, 4694 (1996).
6. Q. A. Pankhurst, J. Conoly, S. K. Jones, and J. Dobson, Applications of magnetic nanoparticles in biomedicine. J. Phys. D: Appl. Phys. 36, R167 (2003).
7. M. W. Freeman, A. Arrott, and J. H. L Watson, Magnetism in medicine. J. Appl. Phys. 31, S404 (1960).
8. R. D. Kopke, R. A. Wassel, F. Mondalek, B. Grady, K. Chen, J. Liu, D. Gibson, and K. J. Dormer, Magnetic nanoparticles: Inner ear targeted molecular delivery and middle ear implant. Audiol. Neurotol. 11, 23 (2006).
9. R. D. Kopke, M. E. Hoffer, D. Wester, M. J. O'Leary, and R. L. Jackson, Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol. Neurotol. 22, 475 (2001).
10. T. Tamura, T. Kita, T. Nakgawa, T. Endo, T. S. Kim, T. Ishihara, Y. Mizushima, M. Higaki, and J. Ito, Drug delivery to the cochlea using PLGA nanoparticles. Laryngoscope 115, 2000 (2005).
11. A. Mitra, B. R. Nan, H. Line, and H. Ghandehari, Nanocarriers for nuclear imaging and radiotherapy of cancer. Curr. Pharm. Des. 12, 4729 (2006).
12. F. J. Hass, P. S. Lee, and R. V. Lourenco, Tagging of iron oxide particles with 99mTc for use in the study of deposition and clearance of inhaled particles. J. Nucl. Med. 17, 122 (1976).
13. T. Banerjee, A. K. Singh, R. K. Sharma, and A. N. Maitra, Labeling efficiency and biodistribution of Technetium-99m labeled nanoparticles: Interference by colloidal tin oxide particles. Int. J. Pharm. 289, 189 (2005).
14. J. Panyam and V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329 (2003).
15. R. A. Wassel, B. Grady, R. D. Kopke, and K. J. Dormer, Dispersion of super paramagnetic iron oxide nanoparticles in poly(D,L-lactide-co-glycolide) microparticles. Colloids and Surfaces A 292, 125 (2007).
16. L. N. Okassa, H. Marchais, L. Douziech-Eyrolles, K. Herve, S. Cohn-Jonathan, E. Munnier, M. Sauce, C. Linassier, P. Dubois, and I. Chourpa, Euro. J. Pharmaceu. Biopharmaceu. 67, 31 (2007).
17. S. Huth, J. Lausier, S. W. Gersting, C. Rudolph, C. Plank, U. Welch, and J. Rosenecker, Insights into the mechanisms of magnetofection using PEI-based magnetofectins for gene transfer. J. Gene Med. 6, 923 (2004).
18. A. L. Barnes, R. A. Wassel, F. Mondalek, K. Chen, K. J. Dormer, and R. D. Kopke, Magnetic characterization of superparamagnetic nanoparticles pulled through membranes. Biomagnetic Res. and Technol. 5, 1 ( 2007).
19. F. G. Mondalek, Y. Y. Zhang, R. Kopke, B. Kropp, and K. J. Dormer, A novel model of the round window membrane in magnetic targeted delivery. J. Nanobiotechnology 4, 4 (2006).
20. S. Bala, S. Hariharan, and M. N. V. R. Kumar, PLGA nanoparticles in drug delivery: The state of the art. Crit. Rev, in Therapeutic Drug Carrier Systems 21, 387 (2004).
21. A. Braden, J. Kashyap, J. Vasir, V. Labhasetwar, and J. K. Vishwananatha, Polymeric nanoparticles for sustained downregulation of Annexin A2 lead to reduction in proliferation and migration of prostate cancer cells. J. Biomed. Nanotech. 3, 148 (2007).
22. S.-J. Lee, J.-R. Jeong, S.-C. Shin, J.-C. Kim, Y.-H. Chang, K.-H. Lee, and J.-D. Kim, Magnetic enhancement of iron oxide nanoparticles encapsulated with poly(D,L-Lactide-co-glycolide). Colloids and Surfaces A Physicochem. Eng. Aspects 255, 19 (2005).
23. 125I sodium alginate-bovine serum albumin nanoparticles. World J. Gastroentererology 5, 57 (1999).
24. T. M. Sanchez, A. S. Vila, I. Soriano, C. Evora, J. L. Vila-Jato, and M. J. Alonso, The role of PEG on the stability of PEG-PLA nanoparticles following oral administration. Colloids Surf. B Biointerfaces 1, 3 (2000).
25. 64Cu-labeled folate-conjugated shell cross-linked nanoparticles for turmor imaging and radiotherapy: Synthesis, radiolabeling, and biologic evaluation. J. Nucl. Med. 46, 1210 (2005).
26. M. Hamoudeh, H. Salim, D. Barbos, C. Paunoiu, and H. Fessi, Preparation and characterization of radioactive dihhenium decacarbonyl-loaded PLLA nanoparticles for radionuclide intratumoral therapy. Eur J. Pharm. Biopharm. 67, 597 (2007).
27. J. C. Hung, G. A. Wiseman, H. W. Wahner, B. P. Mullan, T. R. Taggart, and W. L. Dunn, Filtered technetium-99m-sulfur colloid evaluated for lymphoscintigraphy. J. Nucl. Med. 36, 1895 (1995).
28. M. M. Edreira, L. L. Colombo, J. H. Perez, E. O. Sajaroff, and S. G. de Castiglia, In vivo evaluation of three different 99mTc-labelled radiopharmaceuticals for sentinel lymph node identification. Nucl. Med. Commun. 22, 499 (2001).
29. V. D. Awasthi, B. Goins, R. Klipper, and W. T. Phillips, Accumulation of PEG-liposomes in the inflamed colon of rats: Potential for therapeutic and diagnostic targeting of inflammatory bowel diseases. J. Drug Target. 10, 419 (2002).
30. C.-M. Fu, Y.-F. Wang, Y.-C. Chao, S.-H. Hung, and M.-D. Yang, Directly labeling ferrite nanoparticles with Tc-99m radioisotope for diagnostic applications. IEEE Trans. Magnetism 40, 3003 (2004).
31. M. Tafaghodi, S. Abolghasem, S. Tabassi, M.-R. Jaafari, S. R. Zakavi, and M. Momen-Nejad, Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy. Intl. J. Pharmaceutics 280, 125 (2004).
32. L. H. Reddy, R. K. Sharma, K. Chuttani, A. K. Mishra, and R. R. Murthy, Etoposide-incorporated trapalmitin nanoparticles with different surface charges: Characterization, radiolabeling and biodistribution. The AAPS Journal 6, 1 (2004).
33. S. W. Ziehuis, J.-H. Seppenwoolde, V. A. P. Mateus, C. J. G. Bakker, G. C. Kriger, B. A. Zonnerberg, A. D. Van bet Schip, G. A. Koning, and J. F. W. Nijsen, Lanthanide-loaded liposomes for multimodality imaging and therapy. Cancer Biotherapy and Radiopharmaceut. 21, 520 (2006).
34. N. L. Mills, N. Amin, S. D. Robinson, A. Anand, J. Davies, D. Patel, J. M. de la Fuente, F. R. Cassee, N. A. Boon, W. MacNee, A. M. Millar, K. Donaldson, and D. E. Newby, Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am. J. Resir. Crit. Care Med. 173, 426 (2006).
35. M. M. Kleither, D. Yu, L. A. Mohammadian, N. Niehaus, I. Spasojevic, L. Saunders, B. L. Viglanti, P. S. Yamolenko, M. Hauck, N. A. Petry, T. Z. Wong, M. W. Dewhirst, and D. E. Thrall, A tracer dose of technetium-99-m-labeled liposomes can estimate the effect of hyperthermia on intratumoral doxil extravasation. Clin. Cancer Res. 12, 6800 (2006).
36. K. H. Park, H. C. Song, K. Na, H. S. Bom, K. H. Lee, S. Kim, D. Kang, and D. H. Lee, Ionic strength-sensitive pullulan acetate nanoparticles (PAN) for intratumoral administration of radioisotope: Ionic strength-dependent aggregation behavior and (99m) Technetium retention property. Colloids Surf. B Biointerfaces 59, 16 (2007).
37. S. Liang, Y. Wang, J. Yu, J. Xia, and D. Yin, Surface modified superparamagnetic iron oxide nanoparticles: As a new carrier for biomagnetically targeted therapy. J. Mater. Sci. Mater Med. 18, 2297 (2007).